Capstone Investment Advisors, LLC Regeneron Pharmaceuticals, Inc. Put Options Transaction History

Capstone Investment Advisors, LLC

$30.4 Billion
Q3 2024

Put Options

23 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$1024.09 - $1201.76 $614,454 - $721,056	-600 Reduced 12.24%	4,300 $4.52 Million
Q2 2024 Aug 14, 2024	BUY	$883.2 - $1071.19 $3.27 Million - $3.96 Million	3,700 Added 308.33%	4,900 $5.15 Million
Q1 2024 May 01, 2024	SELL	$902.69 - $993.35 $812,421 - $894,015	-900 Reduced 42.86%	1,200 $1.15 Million
Q4 2023 Feb 12, 2024	BUY	$775.18 - $881.7 $1.16 Million - $1.32 Million	1,500 Added 250.0%	2,100 $1.84 Million
Q1 2023 May 09, 2023	SELL	$680.49 - $826.97 $1.63 Million - $1.98 Million	-2,400 Reduced 80.0%	600 $493,000
Q4 2022 Feb 10, 2023	BUY	$705.89 - $766.39 $70,589 - $76,639	100 Added 3.45%	3,000 $2.16 Million
Q3 2022 Nov 10, 2022	BUY	$573.97 - $724.32 $631,367 - $796,752	1,100 Added 61.11%	2,900 $2 Million
Q2 2022 Aug 15, 2022	SELL	$548.35 - $738.84 $4.5 Million - $6.06 Million	-8,200 Reduced 82.0%	1,800 $1.06 Million
Q1 2022 May 13, 2022	SELL	$595.12 - $698.43 $31.4 Million - $36.8 Million	-52,700 Reduced 84.05%	10,000 $6.98 Million
Q4 2021 Feb 11, 2022	SELL	$543.48 - $670.97 $2.34 Million - $2.89 Million	-4,300 Reduced 6.42%	62,700 $39.6 Million
Q3 2021 Nov 15, 2021	BUY	$574.03 - $680.96 $5.74 Million - $6.81 Million	10,000 Added 17.54%	67,000 $40.5 Million
Q2 2021 Aug 16, 2021	SELL	$472.8 - $558.54 $992,880 - $1.17 Million	-2,100 Reduced 3.55%	57,000 $31.8 Million
Q1 2021 May 17, 2021	SELL	$446.73 - $548.2 $4.33 Million - $5.32 Million	-9,700 Reduced 14.1%	59,100 $28 Million
Q4 2020 Feb 16, 2021	BUY	$478.3 - $607.98 $191,320 - $243,192	400 Added 0.58%	68,800 $33.2 Million
Q3 2020 Nov 16, 2020	BUY	$544.75 - $658.21 $13.3 Million - $16.1 Million	24,400 Added 55.45%	68,400 $38.3 Million
Q2 2020 Aug 14, 2020	BUY	$493.32 - $643.92 $9.47 Million - $12.4 Million	19,200 Added 77.42%	44,000 $27.4 Million
Q1 2020 May 15, 2020	SELL	$336.18 - $494.43 $17.4 Million - $25.6 Million	-51,700 Reduced 67.58%	24,800 $12.1 Million
Q4 2019 Feb 14, 2020	BUY	$274.13 - $376.51 $5.78 Million - $7.94 Million	21,100 Added 38.09%	76,500 $28.7 Million
Q3 2019 Nov 14, 2019	BUY	$273.46 - $318.39 $273,460 - $318,390	1,000 Added 1.84%	55,400 $15.4 Million
Q2 2019 Aug 14, 2019	BUY	$299.6 - $414.82 $1.56 Million - $2.16 Million	5,200 Added 10.57%	54,400 $17 Million
Q1 2019 May 15, 2019	BUY	$372.08 - $439.57 $14.1 Million - $16.7 Million	38,000 Added 339.29%	49,200 $20.2 Million
Q4 2018 Feb 14, 2019	BUY	$335.82 - $403.04 $1.28 Million - $1.53 Million	3,800 Added 51.35%	11,200 $4.18 Million
Q3 2018 Nov 14, 2018	BUY	$351.14 - $408.51 $2.6 Million - $3.02 Million	7,400 New	7,400 $2.99 Million

Others Institutions Holding REGN

# of Institutions

1,529

Shares Held

84.1M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $81.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capstone Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capstone Investment Advisors, LLC with notifications on news.

Account